As of 2024-09-14, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (10.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -581.0%.
The range of the Relative Valuation is (6.63) - (9.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.1x - 8.3x | 4.9x |
| Forward P/E multiples | 6.1x - 22.1x | 14.7x |
| Fair Price | (6.63) - (9.04) | (10.73) |
| Upside | -397.4% - -505.4% | -581.0% |
| Date | P/E |